OAd-B7H3-BiTE

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameOAd-B7H3-BiTE
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagersBiologics > Oncolytic virus +[4] 
Mechanisms of ActionAnti-CD276Anti-CD3CD3 T-cell engagers
TargetsCD276 antigenT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Medical University, ChinaBionce Biotechnology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionce Biotechnology LtdChina Medical University, China
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A